It is an exciting time for preventive cardiology with new therapies and medications being produced and shift in focus to preventing cardiovascular disease. Dr Martha Gulati (President-Elect of the American Society for Preventive Cardiology [ASPC]) reveals how the society are helping to communicate these developments and provide more practical resources and information. She is looking […]

Dr Martha Gulati (President-Elect of the American Society for Preventive Cardiology [ASPC]) provides a sneak peak into the exciting programme at the ASPC 2022 Congress on CVD Prevention on 29th – 31st July in Kentucky, USA. The meeting theme is the ‘ABCs of prevention’, and aims to raise awareness of the many ways in which […]

Heart disease is the leading cause of death for women in the USA but so many are unaware of this prevalence. Dr Martha Gulati (President-Elect of the American Society for Preventive Cardiology) provides her advice regarding knowing the signs of heart disease, recognizing whether you are at risk and taking the necessary actions to help […]

The SuperWIN study is a supermarket and web-based intervention targeting nutrition. touchCARDIO spoke to Prof Dylan Steen (University of Cincinnati Medical Center, Cincinnati, OH, USA) to discuss his presentation at the American College of Cardiology Annual Meeting 2022 entitled ‘SuperWIN: A Multisite, Randomized, Controlled Trial of a Supermarket and Web-based Intervention Targeting Nutrition For Cardiovascular […]

Atrial fibrillation (AF) is the most common type of treated cardiac arrhythmia. The prevalence of the condition increases with age, and it presents with a wide spectrum of symptoms and severity. As the population ages, particularly in developed countries, the burden of AF increases.1 Compared with sinus rhythm, AF is also associated with an increased incidence of […]

Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory coronavirus 2 (SARS-CoV-2), has been associated with several cardiovascular disease manifestations, including acute coronary syndromes, arrhythmias, heart failure, thromboembolic complications and myocardial injury.1 Myocardial injury, defined as elevation in serum cardiac troponin levels, can occur with myocarditis, stress cardiomyopathy and microvascular thrombosis, and is associated with […]

Cardiogenic shock (CS) is a life-threatening condition characterized by cardiac pump dysfunction resulting in end-organ hypoperfusion and hypoxia.1,2 Although multiple treatment strategies have been explored in clinical trials, optimal therapy for CS is still debatable and mortality remains substantially high at around 50%.1 This need for improved treatment, together with a growing burden of patients with congestive […]

Nearly half of patients who present with angina have non-obstructed coronary arteries (ANOCA).1 A significant proportion of these patients have a coronary vasomotor dysfunction, such as coronary microvascular disease and/or coronary artery spasm.2,3 Vasospastic angina (VSA) refers to a dysfunctional state where there is sudden coronary flow attenuation as a result of either epicardial or microvascular spasm, […]